Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS)
CNY 11.25
(2.18%)
CNY 11.25
(2.18%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 237.6 Million CNY | 77.27% |
| 2022 | 134.03 Million CNY | 250.38% |
| 2021 | 38.25 Million CNY | 53.02% |
| 2020 | 25 Million CNY | 400.0% |
| 2019 | 5 Million CNY | -75.0% |
| 2018 | 20 Million CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | -100.0% |
| 2014 | 47 Million CNY | -6.0% |
| 2013 | 50 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 357.54 Million CNY | 17.87% |
| 2024 Q3 | 377.37 Million CNY | -16.17% |
| 2024 Q1 | 303.32 Million CNY | 27.66% |
| 2023 Q1 | 128.04 Million CNY | -4.47% |
| 2023 Q3 | 183.96 Million CNY | 11.2% |
| 2023 Q2 | 165.43 Million CNY | 29.2% |
| 2023 Q4 | 237.6 Million CNY | 29.16% |
| 2023 FY | 237.6 Million CNY | 77.27% |
| 2022 Q3 | 149.92 Million CNY | 38.85% |
| 2022 Q1 | 93.6 Million CNY | 144.69% |
| 2022 FY | 134.03 Million CNY | 250.38% |
| 2022 Q4 | 134.03 Million CNY | -10.6% |
| 2022 Q2 | 107.97 Million CNY | 15.35% |
| 2021 Q3 | 29.06 Million CNY | -5.34% |
| 2021 FY | 38.25 Million CNY | 53.02% |
| 2021 Q4 | 38.25 Million CNY | 31.64% |
| 2021 Q2 | 30.69 Million CNY | -2.5% |
| 2021 Q1 | 31.48 Million CNY | 25.95% |
| 2020 Q4 | 25 Million CNY | 0.0% |
| 2020 FY | 25 Million CNY | 400.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2019 FY | 5 Million CNY | -75.0% |
| 2019 Q4 | 5 Million CNY | 0.0% |
| 2018 FY | 20 Million CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 Q1 | 5 Million CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q3 | - CNY | -100.0% |
| 2017 Q2 | 5 Million CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 FY | - CNY | 0.0% |
| 2015 Q3 | 32 Million CNY | 0.0% |
| 2015 FY | - CNY | -100.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | 32 Million CNY | 0.0% |
| 2014 FY | 47 Million CNY | -6.0% |
| 2013 FY | 50 Million CNY | 0.0% |